In this episode, join A/Prof Catherine Hill and Dr Rani Sinnathurai as they highlight a range of rheumatology resources developed as part of the Value in Prescribing bDMARDs Program.
They discuss the many resources for inflammatory arthritis that are now available for rheumatologists, consumers and other health professionals. 
In particular, the value of key resources is featured as well as how they have been used in practice.

For more information and to access these resources see: 

• the NPS MedicineWise bDMARDs program webpage: https://www.nps.org.au/bdmards or 
• the ARA Value in Prescribing webpage:  https://rheumatology.org.au/For-Healthcare-Professionals/Value-in-Prescribing-Program 

This podcast is funded by the Australian Government Department of Health through the Value in Prescribing bDMARDs Program grant.”

Clinicians who treat vasculitis are familiar with uncertainty.

In its many forms, and with no single sign, symptom or investigation strong enough to confirm a diagnosis, vasculitis presents an extensive list of challenges in a setting where diagnostic delay can lead to devastating consequences.

In episode three of our Rheumatology Advanced Trainee series we deep dive into two types of vasculitis -

giant cell arteritis (GCA) here in part 1 and ANCA-associated vasculitis next week in part 2. You'll hear Dr Tony Sammel and Dr Daman Langguth discuss what they’ve learned about how to diagnose the rare condition and how to best support patients through treatment decisions and relapse. They’ll share tips on how to overcome some of the challenges associated with ruling out other more common conditions, making decisions around imaging and biopsy as well as discussing some of the latest evidence around treatments.

With many practical tips and insights, this episode is a great listen. Dr Daman Langguth is VMO at Wesley Hospital, Brisbane, director of Immunology and chair of Partners Sullivan Nicolaides Pathology and treasurer of the Australian and New Zealand Vasculitis Society.

Dr Tony Sammel is a staff specialist in rheumatology at Prince of Wales Hospital in Randwick and Sydney Eye Hospitals, where he coordinates the rheumatology vasculitis service, he has teaching appointments at the University of NSW and is Director of the Australian and New Zealand Vasculitis Society.

This series is a collaboration with the Australian Rheumatology Association and the limbic. 

Clinicians who treat vasculitis are familiar with uncertainty.

In its many forms, and with no single sign, symptom or investigation strong enough to confirm a diagnosis, vasculitis presents an extensive list of challenges in a setting where diagnostic delay can lead to devastating consequences.

In episode three of our Rheumatology Advanced Trainee series we deep dive into two types of vasculitis -

giant cell arteritis (GCA) here in part 1 and ANCA-associated vasculitis next week in part 2. You'll hear Dr Tony Sammel and Dr Daman Langguth discuss what they’ve learned about how to diagnose the rare condition and how to best support patients through treatment decisions and relapse. They’ll share tips on how to overcome some of the challenges associated with ruling out other more common conditions, making decisions around imaging and biopsy as well as discussing some of the latests evidence around treatments.

With many practical tips and insights this episode is a great listen. Dr Daman Langguth is VMO at Wesley Hospital, Brisbane, director of Immunology and chair of Partners Sullivan Nicolaides Pathology and treasurer of the Australian and New Zealand Vasculitis Society.

Dr Tony Sammel is staff specialist in rheumatology at Prince of Wales Hospital in Randwick and Sydney Eye Hospitals, where he coordinates the rheumatology vasculitis service, he has teaching appointments at the University of NSW and is Director of the Australian and New Zealand Vasculitis Society.

This series is a collaboration with the Australian Rheumatology Association and the limbic. 

In episode 2 of "The Limbic" podcast series for rheumatology advanced trainees we share a fascinating conversation on fibromyalgia with the inspiring Dr Sam Whittle, Dr Emma Guymer and Dr Richard Kwiatek.

In this conversation, you’ll hear about how each practitioner has come to accept and work with the unknowns that come with a  fibromyalgia diagnosis.  They’ll share tips on how to talk to patients about their diagnosis, the ins and outs of working in the public and private setting, overcoming treatment challenges, as well as discussing the rewards that come with being able to walk alongside patients through a journey to self-management. 

Dr Emma Guymer has been engaged in clinical care and research with fibromyalgia patients for over 20 years. She currently heads the Monash Fibromyalgia Clinic at Monash Medical Centre in Melbourne.

Dr Richard Kwiatek works primarily in private rheumatology practice and has a long-standing clinical and research interest in medically unexplained pain and fatigue syndromes.

Dr Sam Whittle is a senior consultant rheumatologist at the Queen Elizabeth Hospital in Adelaide and a senior lecturer at the University of Adelaide He is a Board member of the Australian Rheumatology Association and sits on the Steering Committee of the South Australian Statewide Chronic Pain Clinical Network.

This series is a collaboration with the Australian Rheumatology Association and the limbic.

In episode 1 of "The Limbic" podcast series for rheumatology for advanced trainees, we’re excited to introduce the brilliant Dr David Liew and Dr Tina Racunica on biologics. 

In this episode, Professor Debra Rowett is joined by Professor Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee and Dr Paul Kubler, Consultant Rheumatologist to discuss how b/tsDMARDs are funded in Australia, the policies and mechanisms that influence the cost to government and how the introduction of biosimilars affects the pricing of biologics on the PBS. 

In this episode of ARA Audio Rheum, ARA President Prof. Catherine Hill talks to Prof. Liana Fraenkel. Prof. Fraenkel is the principal investigator of the 2020 ACR Guidelines for pharmacological management of rheumatoid arthritis (RA). In this podcast they discuss the contemporary role of methotrexate and glucocorticoids in RA.

Join our conversation between Professor Rachelle Buchbinder, Monash University, and Professor Christopher Edwards, University of Southhampton, UK, discussing the new Down-Titration Living Guidelines

This podcast is funded by the Australian Government Department of Health through the Value in Prescribing bDMARDs Program grant.
Developed with the guidance of members of the Targeted Therapies Alliance

For further information please go to
nps.org.au/bdmards   or   rheumatology.org.au